CR Form 4: Alcala Exercises Options, Reports ~33,526 Shares Held
Rhea-AI Filing Summary
Alejandro Alcala, Exec. V.P. & Chief Operating Officer of Crane Co (CR), reported option exercises and market sales on 08/25/2025. He exercised options to acquire 12,134 shares at a $51.32 exercise price and 8,657 shares at a $64.86 exercise price. On the same date he sold 15,358 shares, 4,800 shares and 633 shares at weighted average prices in ranges reported between $191.85 and $194.34 per share. Following these transactions the reporting person beneficially owned 33,526 shares directly and 290 shares indirectly through a 401(k). The Form 4 was signed by Attorney in Fact Anthony M. D'Iorio on 08/27/2025.
Positive
- Timely Section 16 disclosure filed showing compliance with insider reporting requirements
- Options exercise transparency with grant dates and vesting schedules for the exercised grants disclosed
Negative
- Substantial sale volume on 08/25/2025: 20,791 shares sold, which reduced immediate direct holdings
- Sale prices reported as ranges rather than per-lot detail (issuer offers to provide separate-price breakdown only upon request)
Insights
TL;DR: Routine insider exercise and sales disclosed; shows liquidity actions by a senior officer without disclosed material nonpublic information.
The filing documents option exercises that were near expiration and subsequent market sales executed the same day. Exercises used long-dated grants from 2017 and 2018 and resulted in increased share ownership before portions were sold. The report is straightforward and complies with Section 16 disclosure timing, reducing governance risk from late reporting. No new operational or financial details about Crane Co are disclosed.
TL;DR: Insider realized proceeds by selling ~20,791 shares after exercising ~20,791 stock-option-derived shares; transaction sizes are modest relative to large-cap norms.
The options exercised totaled 20,791 shares (12,134 at $51.32; 8,657 at $64.86) and the reported sales on 08/25/2025 disposed of 20,791 shares at weighted average prices disclosed in ranges from $191.85 to $194.34. Post-transaction direct beneficial ownership is 33,526 shares plus 290 held indirectly. The filing documents mechanics of compensation-derived liquidity; it includes price ranges for sales and an undertaking to provide per-price detail on request.